Company intelligence / Profile preview
Sitryx
Oxford, UKsitryx.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Phase 1
01
Overview
Sitryx is developing a broad pipeline of first-in-class and best-in-class small molecule therapeutics that target immunometabolic pathways. The company’s lead programs are advancing through preclinical development with some approaching or entering Phase 1 trials. Their approach aims to rebalance the immune system by modulating cell metabolism for durable remission in chronic autoimmune and inflammatory diseases. No late-stage clinical results have been reported yet.
- Therapeutic areas
- GastroenterologyPulmonologyDermatologyImmunology
- Modalities
- Small moleculesMetabolic pathway modulators
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly – exclusive global licensing and research collaboration worth up to $1.1 billion in milestones plus royalties; allows Lilly to develop/commercialize up to four immunometabolism-targeted therapeutics from Sitryx’s pipeline.Sygnature Discovery – CRO partner supporting early drug discovery work that enabled progression toward pharma partnership.
Beyond the preview
Go deeper on Sitryx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sitryx.